Partnerships
Alliances and collaborations are how this scales
We are expanding our partnerships in neurodegeneration, all-cause mortality and biological age. If that is your field, we would like to talk.
Research-led, and open to collaborators
Aromha's co-founder, Dr. Mark Albers, MD, PhD, is an Associate Professor of Neurology at Harvard Medical School and a neurologist at Massachusetts General Hospital.
We know that alliances and collaborations are what turn a screening test into a standard of care. Get in touch to be part of it.
Partner programs
Whoever your people are, there is a route to offering them the test.
-
Audiologists
Audiologists are on the front line of dementia; hearing loss is one of the most important modifiable risk factors.
-
Clinicians
Bring your patients a brain health screening experience that fits into the visit they already have.
-
Healthcare professionals
Wellness and longevity. We all care about guiding the people we look after.
-
Sales partners
Help people screen for olfactory loss early, and build a business doing it.
-
Distributors
Add the Aromha Brain Health Test to your catalogue and bring it to your clientele.
-
International partners
Aromha is expanding globally, and the test itself is delivered in multiple languages. Which market will you lead?
-
Clinical trial recruitment
Streamline your screening process and reduce recruitment cost.
-
Research partners
Use the test as a validated olfactory measurement instrument in your study.
Ready to talk?
Tell us about your organisation and we will get you set up.